FDA approves Genentech’s Vabysmo Prefilled Syringe (PFS) for three leading causes of vision loss Read more
Signet Therapeutics announces IND approval by the FDA for world’s first targeted therapy for DGC Read more
FDA approval of CAPVAXIVE will enhance protection against pneumococcal disease in older adults: GlobalData Read more